Sara M. Centuori, PhD, is a Research Assistant Professor of Medicine, and Director of the Flow Cytometry and Immune Monitoring Shared Resource at the University of Arizona Cancer Center. She received her PhD from the University of Arizona in 2011 in the area of Cancer Biology with a predominant focus in the area of Tumor Immunology. She completed her postdoctoral training in 2018 also at the University of Arizona, where she received two T32 training awards, an R01 Minority Supplement, and actively served on the UArizona Cancer Center executive committee as postdoctoral representative. Her education and training resulted in unique expertise in Cancer Prevention and Immune Profiling of human biospecimens.
Dr. Centuori is a clinical and translational researcher focusing on the identification of novel immunomodulatory agents for the prevention and treatment of cancer. Her research interests focus on early stage clinical trials that examine the immuneprevention and immunotherapeutic properties of pharmaceutical and nutraceuticals agents with a special interest in obesity-associated breast and tobacco-related head and neck cancers. She is a recent recipient of an NCI-awarded Early Stage Investigator Research Supplement to Promote Diversity in Health-Related Research associated with the University of Arizona’s Cancer Prevention Clinical Trials Network (CP-CTNet). In this role she participates in the design, development, and execution early-stage cancer prevention trials, and emphasizes on driving minority recruitment to reduce health disparities in cancer prevention trials. She is also an active member of the Skin Cancer Prevention Program and the Head and Neck Translational Oncology group.